Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradePhilip J. Johnson, Hidenori Toyoda, Sarah Berhane et al.|Journal of Clinical Oncology|2014Cited by 2.8k
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaWinnie Yeo, Philip J. Johnson, Pun Hui et al.|JNCI Journal of the National Cancer Institute|2005Cited by 591
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistanceNathalie Wong, Ka‐Fai To, Winnie Yeo et al.|International Journal of Cancer|2008Cited by 196
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeHidenori Toyoda, Philip J. Johnson, Paul B.S. Lai et al.|British Journal of Cancer|2016Cited by 177
Integration of albumin–bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinomaAnthony W.H. Chan, Stephen L. Chan, Takshi Kumada et al.|Journal of Gastroenterology and Hepatology|2016Cited by 123